The rate of cleavage secretion of the enzymatically active ectodomain of angiotensin-converting enzyme (ACE) is regulated by tyrosine phosphorylation of the protein and by the phorbol ester, phorbol 12-myristate 13-acetate (PMA), an activator of protein kinase C. Here, we report that both calmodulin inhibitor (CaMI) and calmodulin kinase inhibitor could also enhance cleavage secretion of ACE. This effect was accompanied by the dissociation of calmodulin from a specific region within the cytoplasmic domain of ACE to which it had been bound. The same domain of ACE was phosphorylated, and both CaMI and PMA caused dephosphorylation of ACE as well. Mass spectrometric and mutational analyses identified Ser 730 as the only phosphorylated residue in the cytoplasmic domain of ACE. The Ser 730 3 Ala mutant of ACE was not phosphorylated, but it still bound calmodulin, and its cleavage secretion was enhanced by both CaMI and PMA. Similarly, when Ser 730 was replaced by the phosphoserine mimetic, Asp, cleavage secretion of the resultant mutant remained susceptible to the enhancing effect of CaMI and PMA. These results demonstrate that, although CaMI and PMA can enhance both cleavage secretion of ACE and its dephosphorylation, the two effects are not mutually interdependent.Numerous integral membrane proteins can release their biologically active ectodomain from the cell surface to the extracellular milieu by a regulated proteolytic event called "ectodomain shedding" (1-3). Ectodomain shedding plays a vital role in various cellular functions, including cell growth (4), mammalian development (5), and disease (4, 6). The group of proteins that undergo ectodomain shedding includes growth factors, receptors, cell adhesion molecules, ectoenzymes such as angiotensin-converting enzyme (ACE), 3 and others, e.g. -amyloid precursor protein (7,8). The proteases responsible for ectodomain shedding, the "sheddases," are also a member of transmembrane protein family (7). Some of the proteolytic events are carried out by ADAM (a disintegrin and metalloproteinase) family of proteases (9). Tumor necrosis factor-␣-converting enzyme (TACE, also known as ADAM 17), was the first secretase with known physiological substrate (tumor necrosis factor-␣) to be isolated and characterized (10,11). TACE is also involved in shedding of a number of transmembrane proteins, including L-selectin (12), -amyloid precursor protein (13), epidermal growth factor receptor ligands (14, 15), and growth factor receptors (16 -18).ACE (also known as kininase II and CD143) is a central component of the renin-angiotensin system, which regulates blood pressure, electrolyte balance, and fluid homeostasis. ACE participates in blood pressure regulation by converting inactive decapeptide angiotensin I to vasoactive octapeptide angiotensin II and by inactivating the vasodilator bradykinin. ACE exists as two isoforms, namely somatic ACE (sACE) and germinal ACE (gACE), which are generated from the same gene with tissue-specific choice of transcription from two alternative promot...